The graphic above shows the research and development plans for Oxford Vacmedix UK.
.
- OVM-100 is a cancer vaccine targeting HPV related tumours such as cervical cancer and head and neck cancer ,
- OVM-200 is a cancer vaccine targeting survivin (inhibitor of apoptosis protein) over expressed in most solid tumours including lung, breast, prostate and ovarian cancers.
.